Ji-dong S. Jia

95 Yong An Road
Beijing, 100050, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 136 publications

APASL clinical practice guidance: the diagnosis and management of patients with Wilson's disease.

APASL clinical practice guidance: the diagnosis and management of patients with Wilson's disease.

Journal: Hepatology international
Published: February 27, 2026

Beyond side effects: treatment-related adverse events are associated with improved survival outcomes in HCC patients on atezolizumab-bevacizumab therapy.

Beyond side effects: treatment-related adverse events are associated with improved survival outcomes in HCC patients on atezolizumab-bevacizumab therapy.

Journal: BMC cancer
Published: December 03, 2025

Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia.

Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia.

Journal: Hepatology international
Published: September 06, 2025

Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial.

Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial.

Journal: Nature medicine
Published: September 02, 2025

Direct bilirubin was superior to total bilirubin in predicting the long-term outcomes of patients with primary biliary cholangitis.

Direct bilirubin was superior to total bilirubin in predicting the long-term outcomes of patients with primary biliary cholangitis.

Journal: BMC gastroenterology
Published: September 02, 2025

Factors associated with recompensation and criteria for etiological suppression in patients with primary biliary cholangitis.

Factors associated with recompensation and criteria for etiological suppression in patients with primary biliary cholangitis.

Journal: Journal of gastroenterology
Published: August 11, 2025

Impact of temporary atezolizumab and bevacizumab interruption on survival in advanced HCC: an IMbrave150 analysis.

Impact of temporary atezolizumab and bevacizumab interruption on survival in advanced HCC: an IMbrave150 analysis.

Journal: The oncologist
Published: June 09, 2025

Rice-derived recombinant human serum albumin as an alternative to human plasma for patients with decompensated liver cirrhosis: a randomised, double-blind, positive-controlled and non-inferiority trial.

Rice-derived recombinant human serum albumin as an alternative to human plasma for patients with decompensated liver cirrhosis: a randomised, double-blind, positive-controlled and non-inferiority trial.

Journal: Gut
Published: April 15, 2025

Management of acute variceal bleeding: updated APASL guidelines.

Management of acute variceal bleeding: updated APASL guidelines.

Journal: Hepatology international
Published: March 27, 2025

Bavachinin causes cholestasis by down-regulating BAAT expression and disrupting glycocholic acid synthesis in human liver organoids.

Bavachinin causes cholestasis by down-regulating BAAT expression and disrupting glycocholic acid synthesis in human liver organoids.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: February 04, 2025

Association of pre-diagnosis plasma proteomic contexture with overall survival of early- and late-stage colon cancer patients.

Association of pre-diagnosis plasma proteomic contexture with overall survival of early- and late-stage colon cancer patients.

Journal: BMC cancer
Published: December 11, 2024

Double-negative T cells in combination with ursodeoxycholic acid ameliorates immune-mediated cholangitis in mice.

Double-negative T cells in combination with ursodeoxycholic acid ameliorates immune-mediated cholangitis in mice.

Journal: BMC medicine
Published: November 03, 2024
Showing 1-12 of 136

Last Updated: 09/26/2026